HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 2,585.00
+45.00 (1.77%)
At close: Mar 19, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 110.95 billion as of March 20, 2026. Its market cap has decreased by -15.01% in one year.
Market Cap
110.95B
Enterprise Value
85.04B
Revenue
14.29B
Ranking
n/a
PE Ratio
66.42
Stock Price
2,585.00
Market Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 110.95B, an increase of 541.69%. That is a compound annual growth rate of 7.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 110.95B | 40.55% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 481.82B |
| Dx & Vx | 441.94B |
| GENINUS | 201.78B |
| Cytogen | 107.73B |
| Green Cross Medical Science | 80.23B |
| Protia | 64.19B |
| Seoulin Bioscience | 58.52B |
| GeneMatrix | 42.62B |